These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18080025)

  • 1. [Ertapenem].
    Gobernado M; Acuña C
    Rev Esp Quimioter; 2007 Sep; 20(3):277-99. PubMed ID: 18080025
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta-lactam antibiotics].
    Suárez C; Gudiol F
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):116-29. PubMed ID: 19254642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Lactam and glycopeptide antibiotics: first and last line of defense?
    Jovetic S; Zhu Y; Marcone GL; Marinelli F; Tramper J
    Trends Biotechnol; 2010 Dec; 28(12):596-604. PubMed ID: 20970210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
    Arguedas A; Cespedes J; Botet FA; Blumer J; Yogev R; Gesser R; Wang J; West J; Snyder T; Wimmer W;
    Int J Antimicrob Agents; 2009 Feb; 33(2):163-7. PubMed ID: 18945594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis: ertapenem for complicated intra-abdominal infections.
    Falagas ME; Peppas G; Makris GC; Karageorgopoulos DE; Matthaiou DK
    Aliment Pharmacol Ther; 2008 May; 27(10):919-31. PubMed ID: 18266994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Part II. Introduction to the beta-lactam antibiotics.
    Cooper TW; Gibbs WJ; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2006 Oct; 99(10):516-20. PubMed ID: 17125105
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Karamanis EM, Matthaiou DK, Moraitis LI, et al. Fluoroquinolones versus beta-lactam based regimens for the treatment of osteomyelitis: a meta-analysis of randomized controlled trials. Spine 2008;33:E297-E304.
    Kłuciński P; Ekiel A; Wilk I; Martirosian G
    Spine (Phila Pa 1976); 2009 Feb; 34(4):420; author reply 420-1. PubMed ID: 19214107
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians.
    Nix DE; Majumdar AK; DiNubile MJ
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii23-8. PubMed ID: 15150180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is monotherapy with β-lactam antibiotics still up to date? New aspects for treatment of severe infections].
    Heizmann P; Lode H; Heizmann WR
    Dtsch Med Wochenschr; 2012 Feb; 137(6):267-70. PubMed ID: 22294112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Part V. Other beta-lactam antimicrobials.
    Gibbs WJ; Cooper TW; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2007 Jan; 100(1):23-5. PubMed ID: 17378498
    [No Abstract]   [Full Text] [Related]  

  • 11. [A comment on the contribution by H. Rosin: "Beta-lactam antibiotics"].
    Cullmann W; Opferkuch W
    Internist (Berl); 1989 Sep; 30(9):628-9. PubMed ID: 2807787
    [No Abstract]   [Full Text] [Related]  

  • 12. Ertapenem or ticarcillin/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients.
    Yellin AE; Johnson J; Higareda I; Congeni BL; Arrieta AC; Fernsler D; West J; Gesser R
    Am J Surg; 2007 Sep; 194(3):367-74. PubMed ID: 17693284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer beta-lactam antibiotics: doripenem, ceftobiprole, ceftaroline, and cefepime.
    Bazan JA; Martin SI; Kaye KM
    Infect Dis Clin North Am; 2009 Dec; 23(4):983-96, ix. PubMed ID: 19909894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity.
    Fisher JF; Meroueh SO; Mobashery S
    Chem Rev; 2005 Feb; 105(2):395-424. PubMed ID: 15700950
    [No Abstract]   [Full Text] [Related]  

  • 15. [The beta-lactam antibiotics].
    Rosin H
    Internist (Berl); 1989 Jan; 30(1):2-12. PubMed ID: 2646236
    [No Abstract]   [Full Text] [Related]  

  • 16. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faropenem medoxomil: a treatment option in acute bacterial rhinosinusitis.
    Hadley JA; Tillotson GS; Tosiello R; Echols RM
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):923-37. PubMed ID: 17181408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-lactams with or without aminoglycosides.
    Alfandari S; Boussekey N
    Clin Infect Dis; 2005 Nov; 41(10):1542-3; author reply 1543-4. PubMed ID: 16231273
    [No Abstract]   [Full Text] [Related]  

  • 19. [Which partner for the betalactam agent in empirical combined therapy? II. Aminoglycoside].
    Mimoz O; Grollier G
    Ann Fr Anesth Reanim; 2004 Jun; 23(6):639-42. PubMed ID: 15234735
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bacampicillin].
    Mashimo K
    Jpn J Antibiot; 1982 Dec; 35(12):2723-35. PubMed ID: 6763634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.